First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of
acquired autoimmune thrombophilia in which patients present with clinical features of …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
occurrence of venous and/or arterial thrombosis and pregnancy morbidity in the presence of …

The antiphospholipid syndrome (APS) is defined by the development of venous and/or
arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses) …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous
thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently …

Hydroxychloroquine (HCQ) was suggested to play a role in lowering antiphospholipid
antibody titers and preventing thrombotic recurrences in patients with systemic lupus …

Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

Tumors are closely related to chronic inflammation, during which there are various changes
in inflammatory sites, such as immune cells infiltration, pro-inflammation cytokines …

Objective. To assess the longterm frequency of thrombotic recurrences, obstetrical
complications, organ damage, severe comorbidities, and evolution toward connective tissue …

Background Young adults with acute myocardial infarction are a critical group to examine for
the purpose of risk factor stratification and modification. In this study we aimed to assess the …

APS is among the most frequent acquired risk factors for a treatable cause of recurrent
pregnancy loss and increases the risk of conditions associated with ischaemic placental …